1. Home
  2. BWMX vs TBPH Comparison

BWMX vs TBPH Comparison

Compare BWMX & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWMX
  • TBPH
  • Stock Information
  • Founded
  • BWMX 1995
  • TBPH 2013
  • Country
  • BWMX Mexico
  • TBPH United States
  • Employees
  • BWMX N/A
  • TBPH N/A
  • Industry
  • BWMX Catalog/Specialty Distribution
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • BWMX Consumer Discretionary
  • TBPH Health Care
  • Exchange
  • BWMX Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • BWMX 447.8M
  • TBPH 464.5M
  • IPO Year
  • BWMX N/A
  • TBPH N/A
  • Fundamental
  • Price
  • BWMX $11.40
  • TBPH $9.02
  • Analyst Decision
  • BWMX Strong Buy
  • TBPH Buy
  • Analyst Count
  • BWMX 1
  • TBPH 4
  • Target Price
  • BWMX $22.50
  • TBPH $13.75
  • AVG Volume (30 Days)
  • BWMX 16.3K
  • TBPH 195.6K
  • Earning Date
  • BWMX 04-24-2025
  • TBPH 05-12-2025
  • Dividend Yield
  • BWMX 12.10%
  • TBPH N/A
  • EPS Growth
  • BWMX N/A
  • TBPH N/A
  • EPS
  • BWMX 0.92
  • TBPH N/A
  • Revenue
  • BWMX $676,704,288.00
  • TBPH $64,381,000.00
  • Revenue This Year
  • BWMX $8.79
  • TBPH $39.34
  • Revenue Next Year
  • BWMX $6.14
  • TBPH $3.63
  • P/E Ratio
  • BWMX $12.42
  • TBPH N/A
  • Revenue Growth
  • BWMX 8.39
  • TBPH 12.12
  • 52 Week Low
  • BWMX $10.05
  • TBPH $7.44
  • 52 Week High
  • BWMX $20.36
  • TBPH $10.90
  • Technical
  • Relative Strength Index (RSI)
  • BWMX 48.91
  • TBPH 35.49
  • Support Level
  • BWMX $11.47
  • TBPH $9.05
  • Resistance Level
  • BWMX $12.00
  • TBPH $9.55
  • Average True Range (ATR)
  • BWMX 0.42
  • TBPH 0.24
  • MACD
  • BWMX 0.01
  • TBPH -0.06
  • Stochastic Oscillator
  • BWMX 32.25
  • TBPH 3.61

About BWMX Betterware de Mexico S.A.P.I. de C.V.

Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided into different categories based on the type of products it sells and includes, kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, and bedroom and wellness products. The JAFRA's segment is divided into fragrance, color, skincare, and toiletries products. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: